Search

6 July 2017 Research Published: Impact of Isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination

6 Jul 2017 - 12:30

SATVI authors have published an article titled  “Impact of Isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination” appearing in the International Journal of Tuberculosis  and Lung Disease.

The research set out to evaluate the long-term effectiveness of infant modified vaccinia Ankara virus-expressing antigen 85A (MVA85A) vaccination against tuberculosis (TB and found that extended follow-up confirms no longterm effectiveness of infant MVA85A vaccination, but a six-fold reduction in TB risk can be attributed to IPT. National TB programmes in high TB burden countries should ensure optimal implementation of IPT for eligible children.).

Click here to view abstract.